API 0.74% $1.35 australian pharmaceutical industries limited

API have been on the nose now for about a year - mostly due to...

  1. 2,000 Posts.
    lightbulb Created with Sketch. 27
    API have been on the nose now for about a year - mostly due to the (unfounded) panic of Amazon entering the market, but also because the industry has pretty low hurdles to competition. Metrics aren't all that compelling, but not bad either, so its mainly emotion that wins out. I suspect it will drift lower before finding a floor - probably above $1, though.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.